Patent Expiry
Patent/Exclusivity Expiry: ACETAMINOPHEN
Other upcoming events for GPCR
Phase 2 ReadoutPhase 2 Readout: aleniglipron
Patent ExpiryPatent/Exclusivity Expiry: LEGUBETI
Phase 3 ReadoutPhase 3 Topline: IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.
Patent ExpiryPatent/Exclusivity Expiry: APADAZ
Patent ExpiryPatent/Exclusivity Expiry: OFIRMEV
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.